VACCINE LAWSUIT  Florida's Attorney General is suing a major drugmaker, saying it misled patients about the benefits of its ...

Florida Attorney General James Uthmeier filed a lawsuit against Pfizer Inc. this week, accusing the pharmaceutical giant of ...

Pfizer's tilrekimig met the Phase II endpoint in atopic dermatitis, improving Week 16 EASI-75 responses across doses versus ...

LITFULO significantly improved facial and total body repigmentation at Week 52 compared to placebo, with continuous improvement starting at Week 24, supporting planned regulatory filings for a ...

Pfizer's revenue over the past twelve months was 0.2% lower than a year earlier. When sales are flat, look at what management ...

Florida Attorney General James Uthmeier is suing Pfizer and CEO Albert Bourla, alleging the company misled consumers about ...

Pfizer is making moves on the dermatology and wider immunology fronts, detailing two phase 3 wins for its oral Janus kinase inhibitor, Litfulo, and a promising phase 2 update for its investigationa | ...

Learn more If you've been looking for high-yield stocks, Pfizer (NYSE: PFE) may have crossed your radar screen. As shares of ...

Florida Attorney General James Uthmeier has filed a major lawsuit against pharmaceutical titan Pfizer and its chief executive ...

Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer and its CEO, Albert ...